These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8978314)

  • 1. The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene.
    Vaandrager JW; Kluin P; Schuuring E
    Blood; 1997 Jan; 89(1):349-50. PubMed ID: 8978314
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.
    Chesi M; Bergsagel PL; Brents LA; Smith CM; Gerhard DS; Kuehl WM
    Blood; 1996 Jul; 88(2):674-81. PubMed ID: 8695815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC.
    Galiègue-Zouitina S; Collyn-d'Hooghe M; Denis C; Mainardi A; Hildebrand MP; Tilly H; Bastard C; Kerckaert JP
    Genes Chromosomes Cancer; 1994 Dec; 11(4):246-55. PubMed ID: 7533528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene.
    Komatsu H; Iida S; Yamamoto K; Mikuni C; Nitta M; Takahashi T; Ueda R; Seto M
    Blood; 1994 Aug; 84(4):1226-31. PubMed ID: 8049438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.
    Jadayel D; Matutes E; Dyer MJ; Brito-Babapulle V; Khohkar MT; Oscier D; Catovsky D
    Blood; 1994 Jun; 83(12):3664-71. PubMed ID: 8204891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S; Agnelli L; Mattioli M; Baldini L; Ronchetti D; Morabito F; Verdelli D; Nobili L; Intini D; Callea V; Stelitano C; Lombardi L; Neri A
    Genes Chromosomes Cancer; 2005 Feb; 42(2):117-27. PubMed ID: 15543617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32).
    Janssen JW; Vaandrager JW; Heuser T; Jauch A; Kluin PM; Geelen E; Bergsagel PL; Kuehl WM; Drexler HG; Otsuki T; Bartram CR; Schuuring E
    Blood; 2000 Apr; 95(8):2691-8. PubMed ID: 10753852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 as the putative bcl-1 oncogene.
    Harris AW; Bodrug SE; Warner BJ; Bath ML; Lindeman GJ; Adams JM
    Curr Top Microbiol Immunol; 1995; 194():347-53. PubMed ID: 7895508
    [No Abstract]   [Full Text] [Related]  

  • 10. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32).
    Akiyama N; Tsuruta H; Sasaki H; Sakamoto H; Hamaguchi M; Ohmura Y; Seto M; Ueda R; Hirai H; Yazaki Y
    Cancer Res; 1994 Jan; 54(2):377-9. PubMed ID: 8275473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
    Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
    Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32).
    Kobayashi H; Saito H; Kitano K; Kiyosawa K; Gaun S; Aoki K; Narita A; Watanabe M; Uchimaru K; Motokura T
    Acta Haematol; 1995; 94(4):199-203. PubMed ID: 8610478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent in situ hybridization analysis of an atypical t(11;14)(q13;q32) without expression of the cyclin D1 gene.
    Raynaud SD; Gratecos N; Simon MP; Chischportich M; Grosgeorge J; Gaudray P; Ayraud N
    Leukemia; 1993 Nov; 7(11):1924-7. PubMed ID: 8231265
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
    Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
    Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
    Seto M; Yamamoto K; Iida S; Akao Y; Utsumi KR; Kubonishi I; Miyoshi I; Ohtsuki T; Yawata Y; Namba M
    Oncogene; 1992 Jul; 7(7):1401-6. PubMed ID: 1535701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels.
    Specht K; Haralambieva E; Bink K; Kremer M; Mandl-Weber S; Koch I; Tomer R; Hofler H; Schuuring E; Kluin PM; Fend F; Quintanilla-Martinez L
    Blood; 2004 Aug; 104(4):1120-6. PubMed ID: 15090460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization.
    Vaandrager JW; Schuuring E; Zwikstra E; de Boer CJ; Kleiverda KK; van Krieken JH; Kluin-Nelemans HC; van Ommen GJ; Raap AK; Kluin PM
    Blood; 1996 Aug; 88(4):1177-82. PubMed ID: 8695834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.
    Shaughnessy J; Gabrea A; Qi Y; Brents L; Zhan F; Tian E; Sawyer J; Barlogie B; Bergsagel PL; Kuehl M
    Blood; 2001 Jul; 98(1):217-23. PubMed ID: 11418483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
    Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.
    Chiecchio L; Dagrada GP; Ibrahim AH; Dachs Cabanas E; Protheroe RK; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Haematologica; 2009 Dec; 94(12):1708-13. PubMed ID: 19996118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.